Portage Biotech Files 6-K, Confirms Foreign Private Issuer Status

Ticker: ATON · Form: 6-K · Filed: Feb 29, 2024 · CIK: 1095435

Portage Biotech INC. 6-K Filing Summary
FieldDetail
CompanyPortage Biotech INC. (ATON)
Form Type6-K
Filed DateFeb 29, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-issuer, compliance

TL;DR

**Portage Biotech just filed a routine 6-K, confirming its foreign private issuer status and ongoing SEC compliance.**

AI Summary

Portage Biotech Inc. (NASDAQ: PRTG) filed a Form 6-K on February 29, 2024, for the month of February 2024, indicating its status as a foreign private issuer. The company, incorporated in the British Virgin Islands, maintains its principal executive office in Tortola and lists a contact in Westport, Connecticut. This filing confirms its ongoing compliance with SEC reporting requirements under the Securities Exchange Act of 1934.

Why It Matters

This filing confirms Portage Biotech's continued compliance with U.S. securities regulations, which is crucial for maintaining investor confidence and market access.

Risk Assessment

Risk Level: low — This is a routine administrative filing that does not contain new material financial or operational information.

Key Players & Entities

FAQ

What type of filing did Portage Biotech Inc. submit?

Portage Biotech Inc. submitted a Form 6-K, which is a 'Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934'.

When was this 6-K filing submitted?

The 6-K filing was submitted on February 29, 2024, for the month of February 2024.

Where is Portage Biotech Inc. incorporated?

Portage Biotech Inc. is incorporated in the British Virgin Islands.

What is Portage Biotech Inc.'s Commission File Number?

Portage Biotech Inc.'s Commission File Number is 001-40086.

Who is the listed company contact person for Portage Biotech Inc. and what is their phone number?

The listed company contact person is Ian Walters, and their phone number is 203.221.7378.

Filing Stats: 196 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2024-02-28 18:42:21

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Portage Biotech Inc. (Registrant) Date: February 28, 2024 /s/ Allan Shaw Allan Shaw Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing